vs
STANDARD BIOTOOLS INC.（LAB）与R F INDUSTRIES LTD（RFIL）财务数据对比。点击上方公司名可切换其他公司
R F INDUSTRIES LTD的季度营收约是STANDARD BIOTOOLS INC.的1.2倍（$22.7M vs $19.6M），R F INDUSTRIES LTD净利率更高（0.8% vs -177.4%，领先178.2%），R F INDUSTRIES LTD同比增速更快（22.9% vs -11.5%），R F INDUSTRIES LTD自由现金流更多（$2.0M vs $-23.1M），过去两年R F INDUSTRIES LTD的营收复合增速更高（29.8% vs -12.2%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
妥思卷工业是一家总部位于美国伊利诺伊州芝加哥的糖果制造商，旗下最知名的产品包括同名的Tootsie Roll软糖以及Tootsie Pop棒棒糖，目前其品牌产品销往加拿大、墨西哥等全球超过75个国家。
LAB vs RFIL — 直观对比
营收规模更大
RFIL
是对方的1.2倍
$19.6M
营收增速更快
RFIL
高出34.4%
-11.5%
净利率更高
RFIL
高出178.2%
-177.4%
自由现金流更多
RFIL
多$25.1M
$-23.1M
两年增速更快
RFIL
近两年复合增速
-12.2%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $22.7M |
| 净利润 | $-34.7M | $173.0K |
| 毛利率 | 48.5% | 36.8% |
| 营业利润率 | -168.5% | 4.0% |
| 净利率 | -177.4% | 0.8% |
| 营收同比 | -11.5% | 22.9% |
| 净利润同比 | -28.8% | 172.7% |
| 每股收益（稀释后） | $-0.09 | $0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LABRFIL
| Q4 25 | — | $22.7M | ||
| Q3 25 | $19.6M | $19.8M | ||
| Q2 25 | $21.8M | $18.9M | ||
| Q1 25 | $40.8M | $19.2M | ||
| Q4 24 | — | $18.5M | ||
| Q3 24 | $22.1M | $16.8M | ||
| Q2 24 | $22.5M | $16.1M | ||
| Q1 24 | $45.5M | $13.5M |
净利润LABRFIL
| Q4 25 | — | $173.0K | ||
| Q3 25 | $-34.7M | $392.0K | ||
| Q2 25 | $-33.5M | $-245.0K | ||
| Q1 25 | $-26.0M | $-245.0K | ||
| Q4 24 | — | $-238.0K | ||
| Q3 24 | $-26.9M | $-705.0K | ||
| Q2 24 | $-45.7M | $-4.3M | ||
| Q1 24 | $-32.2M | $-1.4M |
毛利率LABRFIL
| Q4 25 | — | 36.8% | ||
| Q3 25 | 48.5% | 34.0% | ||
| Q2 25 | 48.8% | 31.5% | ||
| Q1 25 | 48.4% | 29.8% | ||
| Q4 24 | — | 31.3% | ||
| Q3 24 | 54.9% | 29.5% | ||
| Q2 24 | 46.1% | 29.9% | ||
| Q1 24 | 53.1% | 24.5% |
营业利润率LABRFIL
| Q4 25 | — | 4.0% | ||
| Q3 25 | -168.5% | 3.6% | ||
| Q2 25 | -118.1% | 0.6% | ||
| Q1 25 | -80.8% | 0.3% | ||
| Q4 24 | — | 0.5% | ||
| Q3 24 | -120.9% | -2.5% | ||
| Q2 24 | -134.5% | -2.6% | ||
| Q1 24 | -132.2% | -15.5% |
净利率LABRFIL
| Q4 25 | — | 0.8% | ||
| Q3 25 | -177.4% | 2.0% | ||
| Q2 25 | -153.7% | -1.3% | ||
| Q1 25 | -63.8% | -1.3% | ||
| Q4 24 | — | -1.3% | ||
| Q3 24 | -122.0% | -4.2% | ||
| Q2 24 | -203.3% | -26.7% | ||
| Q1 24 | -70.6% | -10.1% |
每股收益（稀释后）LABRFIL
| Q4 25 | — | $0.01 | ||
| Q3 25 | $-0.09 | $0.04 | ||
| Q2 25 | $-0.09 | $-0.02 | ||
| Q1 25 | $-0.07 | $-0.02 | ||
| Q4 24 | — | $-0.02 | ||
| Q3 24 | $-0.07 | $-0.07 | ||
| Q2 24 | $-0.12 | $-0.41 | ||
| Q1 24 | $-0.27 | $-0.13 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $5.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $399.7M | $35.2M |
| 总资产 | $539.6M | $73.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资LABRFIL
| Q4 25 | — | $5.1M | ||
| Q3 25 | $129.4M | $3.0M | ||
| Q2 25 | $158.6M | $3.6M | ||
| Q1 25 | $150.9M | $1.3M | ||
| Q4 24 | — | $839.0K | ||
| Q3 24 | $210.6M | $1.8M | ||
| Q2 24 | $269.8M | $1.4M | ||
| Q1 24 | $287.1M | $4.5M |
总债务LABRFIL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $55.2M | — | ||
| Q2 24 | $55.1M | — | ||
| Q1 24 | $55.0M | — |
股东权益LABRFIL
| Q4 25 | — | $35.2M | ||
| Q3 25 | $399.7M | $34.8M | ||
| Q2 25 | $424.5M | $34.2M | ||
| Q1 25 | $454.6M | $34.2M | ||
| Q4 24 | — | $34.1M | ||
| Q3 24 | $489.3M | $34.1M | ||
| Q2 24 | $510.3M | $34.6M | ||
| Q1 24 | $577.3M | $38.7M |
总资产LABRFIL
| Q4 25 | — | $73.0M | ||
| Q3 25 | $539.6M | $73.2M | ||
| Q2 25 | $557.0M | $72.7M | ||
| Q1 25 | $579.6M | $70.4M | ||
| Q4 24 | — | $71.0M | ||
| Q3 24 | $681.5M | $71.9M | ||
| Q2 24 | $708.7M | $72.8M | ||
| Q1 24 | $777.7M | $79.1M |
负债/权益比LABRFIL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | 0.10× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $2.1M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | $2.0M |
| 自由现金流率自由现金流/营收 | -118.1% | 9.0% |
| 资本支出强度资本支出/营收 | 4.5% | 0.3% |
| 现金转化率经营现金流/净利润 | — | 12.13× |
| 过去12个月自由现金流最近4个季度 | $-111.1M | $4.3M |
8季度趋势，按日历期对齐
经营现金流LABRFIL
| Q4 25 | — | $2.1M | ||
| Q3 25 | $-22.2M | $-311.0K | ||
| Q2 25 | $-20.7M | $2.2M | ||
| Q1 25 | $-30.3M | $601.0K | ||
| Q4 24 | — | $-244.0K | ||
| Q3 24 | $-27.9M | $2.4M | ||
| Q2 24 | $-39.0M | $197.0K | ||
| Q1 24 | $-62.5M | $840.0K |
自由现金流LABRFIL
| Q4 25 | — | $2.0M | ||
| Q3 25 | $-23.1M | $-419.0K | ||
| Q2 25 | $-22.6M | $2.2M | ||
| Q1 25 | $-35.3M | $574.0K | ||
| Q4 24 | — | $-418.0K | ||
| Q3 24 | $-30.1M | $2.1M | ||
| Q2 24 | $-41.0M | $28.0K | ||
| Q1 24 | $-63.3M | $697.0K |
自由现金流率LABRFIL
| Q4 25 | — | 9.0% | ||
| Q3 25 | -118.1% | -2.1% | ||
| Q2 25 | -103.6% | 11.4% | ||
| Q1 25 | -86.6% | 3.0% | ||
| Q4 24 | — | -2.3% | ||
| Q3 24 | -136.4% | 12.6% | ||
| Q2 24 | -182.2% | 0.2% | ||
| Q1 24 | -138.9% | 5.2% |
资本支出强度LABRFIL
| Q4 25 | — | 0.3% | ||
| Q3 25 | 4.5% | 0.5% | ||
| Q2 25 | 8.7% | 0.2% | ||
| Q1 25 | 12.4% | 0.1% | ||
| Q4 24 | — | 0.9% | ||
| Q3 24 | 10.2% | 1.5% | ||
| Q2 24 | 8.6% | 1.0% | ||
| Q1 24 | 1.7% | 1.1% |
现金转化率LABRFIL
| Q4 25 | — | 12.13× | ||
| Q3 25 | — | -0.79× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
RFIL
| US | $20.9M | 92% |
| Non Us | $1.8M | 8% |
